SUN PHARMACEUTICAL INDUSTRIES
Back to All Ratios
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 56.50 | 50.87 | 46.22 | 23.13 | 18.19 |
What is the latest Cash Earnings per Share (CEPS) ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 56.50 |
| Mar2024 | 50.87 |
| Mar2023 | 46.22 |
| Mar2022 | 23.13 |
| Mar2021 | 18.19 |
How is Cash Earnings per Share (CEPS) of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 56.5 | 11.07 | |
| Mar2024 | 50.87 | 10.06 | |
| Mar2023 | 46.22 | 99.83 | |
| Mar2022 | 23.13 | 27.16 | |
| Mar2021 | 18.19 | - | |
Other Financial Ratios of SUN PHARMACEUTICAL INDUSTRIES
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,089.9 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,807.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,718.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,971.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,752.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
| MANKIND PHARMA | ₹98,179.5 Cr | -4.1% | 4.8% | -0.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -2.4% |
3% |
9.6% |
| SENSEX | -0.5% |
-3.3% |
-7.6% |
You may also like the below Video Courses